- Article metrics
- Last updated: Thu, 9 Oct 2025 14:22:49 Z
Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs
Access & Citations
-
- 6341
- Article Accesses
-
- 34
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 138 tweeters
- 3 blogs
- 1 Facebook pages
- 2 news outlets
- 74 Mendeley
This article is in the 97th percentile (ranked 8,297th) of the 332,036 tracked articles of a similar age in all journals and the 92nd percentile (ranked 5th) of the 63 tracked articles of a similar age in Translational Psychiatry
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
an innovative and promising treatment for schizophrenia
Today Headline -
Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs
information for practice -
Outcome Reporting Bias in Antipsychotic Medication Trials
Mad In America -
KarXT: an innovative and promising treatment for schizophrenia
National Elf Service
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.